Skip to main content
. 2022 Jul 5;25(3):318–322. doi: 10.4103/aca.aca_11_22

Table 1.

Characteristics of study cohort (n=42)

1-year survivors (n=28) 1-year nonsurvivors (n=14) P
Age (years) 80 (70-85) 79 (73–83) 0.78
Sex (%) 0.83
 Female 46 50
 Male 54 50
BMI (kg/m2) 27 (24-20) 27 (26-32) 0.47
CCI 4 (3-5) 4 (3-5) 0.89
STS Risk score 8 (7-10) 8 (6-11) 0.58
AVA (cm2) 0.72 (0.70-0.73) 0.72 (0.70-0.73) 0.93
AMG (mm Hg) 38 (30-50) 41 (24-50) 0.77
LVEF (%) 55 (52-65) 55 (39-60) 0.32
NYHA Classification 3 (3-3) 3 (3-3) 0.91
KCCQ12 50 (31-65) 34 (19-61) 0.19
RMSSD 10 (8-23) 23 (17-33) 0.04
SDNN 10 (7-16) 17 (11-40) 0.03
ICU LOS (hours) 52 (30-79) 103 (45-191) 0.03

BMI=Body mass index; CCI=Charlson Comorbidity Index; STS=Society of Thoracic Surgeons; AVA=Aortic Valve Area; AMG=Aortic Valve Mean Gradient; LVEF=Left Ventricular Ejection Fraction; NYHA=New York Heart Association; KCCQ12=Kansas City Cardiomyopathy Questionnaire 12; RMSSD=Root Mean Square of Successive Differences; SDNN=Standard Deviation of NN Intervals; ICU LOS=Intensive Care Unit Length of Stay. Aggregate data are presented as either median (interquartile range) or proportions, and compared using Mann–Whitney U tests or log rank tests and Chi-square tests, respectively.